Century Therapeutics elects three Class II directors and ratifies Ernst & Young at annual meeting

Century Therapeutics, Inc.

Elected Class II directors: Cynthia Butitta, Timothy Walbert, Alessandro Riva; each term until 2026.
Butitta: 50.6M for, 0.8M withheld; Walbert: 47.6M for, 3.9M withheld; Riva: 50.7M for, 0.8M withheld.
Broker non-votes on director election: 3,952,285.
Ratified Ernst & Young as independent auditor for 2023: 55.4M for, 5K against, 2.8K abstentions.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Century Therapeutics, Inc. shareholders approved Ratification of Independent Registered Public Accounting Firm at the 2023-06-27 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2023-06-27

Exact text from the filing

The appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the 2023 fiscal year was ratified, as follows: Votes For Votes Against Abstentions Broker Non-Votes 55,396,113 5,068 2,839 -

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Century Therapeutics, Inc. shareholders approved Election of Class II Directors at the 2023-06-27 meeting.

Proposal: director election
Outcome: passed
Meeting: 2023-06-27

Exact text from the filing

Each of Cynthia Butitta, Timothy Walbert and Alessandro Riva, M.D. were elected to the Board to serve as Class II directors until the 2026 Annual Meeting of Stockholders and until their successors, if any, are elected or appointed, or their earlier death, resignation, retirement, disqualification or removal, as follows: Name For Withheld Broker Non-Votes Cynthia Butitta 50,643,653 808, 082 3,952,285 Timothy Walbert 47,566,726 3,885,009 3,952,285 Alessandro Riva, M.D. 50,658,311 793,424 3,952,285

View on SEC.gov

352 shareholder votes filed in the last 30 days. Browse all shareholder votes →

Century Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-23-076308

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.